Portefeuille d'ETF SBIO (NYSE) - Page 4 | MetaTrader

Afficher le graphique complet Full chart

Aperçu Toutes les participations Heatmap

Principaux titres en portefeuille Market Value Shares Weight %

KALV Kalvista Pharmaceuticals Inc 733.4 K 45.1 K 0.5%

KURA Kura Oncology Inc 677.1 K 77.6 K 0.5%

RIGL Rigel Pharmaceuticals Inc 562.1 K 16.2 K 0.4%

ANRO Alto Neuroscience Inc 545.2 K 27.7 K 0.4%

DSGN Design Therapeutics Inc 530.0 K 50.8 K 0.4%

VNDA Vanda Pharmaceuticals Inc 469.3 K 52.7 K 0.3%

FLGT Fulgent Genetics Inc 422.4 K 27.6 K 0.3%

RGNX Regenxbio Inc 407.9 K 45.1 K 0.3%

ALT Altimmune Inc 400.8 K 93.0 K 0.3%

TECX Tectonic Therapeutic Inc 391.2 K 16.7 K 0.3%

ZURA Zura Bio Ltd 383.6 K 58.0 K 0.3%

UPB Upstream Bio Inc 369.9 K 48.2 K 0.3%

AVXL Anavex Life Sciences Corp 352.8 K 79.6 K 0.3%

FBRX Forte Biosciences Inc 337.4 K 11.2 K 0.2%

AVIR Atea Pharmaceuticals Inc 325.9 K 69.6 K 0.2%

NGNE Neurogene Inc 324.3 K 13.8 K 0.2%

AKBA Akebia Therapeutics Inc 309.8 K 236.5 K 0.2%

TARA Protara Therapeutics Inc 292.7 K 46.0 K 0.2%

DCTH Delcath Systems Inc 280.1 K 31.5 K 0.2%

ACRS Aclaris Therapeutics Inc 277.1 K 96.6 K 0.2%

1
2
3
4
5

Nouvelles

First Quarter Earnings: Sharpening Sector Divergence

3 Reasons To Stick With Growth Stocks In Rotating Markets

Seeking Innovation Beyond Tech? Insight On Healthcare Stocks

Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts

What's The Dominant Trend In Earnings: AI Or Geopolitics?

Medical Technology Stocks: Innovation Endures As Valuations Reset

AI And The Future Of Healthcare

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War

Can Forgotten Biotech Break Out?

A Few Reasons Why Small-Cap ETFs Are Good Bets Now

Concerns Shift From Obsolescence To Oil

CDT Insider Sentiment March 2026: The Probability Race And Barbell Strategies